ACTIVATED CELL THERAPY, INC. – Trademark Portfolio
Entity Type: 03
ACTIVATED CELL THERAPY, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DENDREON. The owner is based in Mountain View, CA.
291 North Bernardo Avenue
Mountain View, CA 94043
Showing of trademarks Trademarks
Trademark Classifications
ACTIVATED CELL THERAPY, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ACTIVATED CELL THERAPY, INC. have?
ACTIVATED CELL THERAPY, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.
What trademark classes does ACTIVATED CELL THERAPY, INC. file in?
ACTIVATED CELL THERAPY, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ACTIVATED CELL THERAPY, INC.'s most well-known trademarks?
ACTIVATED CELL THERAPY, INC.'s registered trademark portfolio includes well-known marks such as DENDREON. These are among 2 currently registered trademarks in the portfolio.
What is ACTIVATED CELL THERAPY, INC.'s trademark registration success rate?
ACTIVATED CELL THERAPY, INC. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.